Skip to content
E15 – Space Drugs & Hypersonics episode artwork

Aug 13, 2023 51 min

E15 – Space Drugs & Hypersonics

from The Merge Hosted by The Merge

Mike and Jake host Varda Delian Asparouhov, Founders Fund partner and co-founder of Varda Space Industries, to talk about venture capital investing, Varda’s efforts to make drugs in space, and why the Air Force is interested in using their orbiting pharmaceutical lab to help test hypersonic weapons. For those who like #military #technology #airforce #aviation #aerospace #space ---- Links • Sign up for our ⁠amazing newsletter⁠! • Support us on ⁠Patreon⁠ • ⁠Mike Benitez LinkedIn⁠ • Jake Chapman X (Twitter) • Delian Asparouhov X (Twitter) ---- Follow us on... • ⁠Instagram⁠ • ⁠Facebook⁠ • ⁠X (Twitter)⁠ • ⁠LinkedIn⁠ • ⁠Website⁠ ---- Show Notes (00:47) intro (05:00) Varda’s connection to Palantir and Anduril (06:22) Varda’s origin story (08:58) how to find a co-founder (11:42) why drugs (13:23) naming the company (15:39) the space capsule (17:08) Falcon 9 launched into space (19:00) why Ritonavir (22:19) patent a space drug? (26:47) stuck in orbit? (28:27) how it comes back to Earth (30:20) how the Air Force became a customer (33:40) China’s hypersonic news (34:23) Varda’s Air Force STRATFI contract (37:14) Varda’s mission (39:17) Silicon Valley and Congress (42:48) Defense tech investing (47:31) lightning round (56:00) outro

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

E15 – Space Drugs & Hypersonics

0:00 51:38

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Merge?

This episode is 51 minutes long.

When was this The Merge episode published?

This episode was published on August 13, 2023.

Can I download this The Merge episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.